Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sagar, Vishal"'
Autor:
Sagar, Vishal1 (AUTHOR) vishalsagar86@gmail.com
Publikováno v:
Journal of Asian Economic Integration. Apr2024, Vol. 6 Issue 1, p123-127. 5p.
Autor:
Sagar, Vishal1 (AUTHOR) vishalsagar86@gmail.com
Publikováno v:
Journal of Asian Economic Integration. Apr2023, Vol. 5 Issue 1, p95-100. 6p.
Publikováno v:
International Journal of Business Innovation and Research; 2023, Vol. 31 Issue: 3 p295-316, 22p
Publikováno v:
International Journal of Business Excellence; 2023, Vol. 29 Issue: 3 p309-325, 17p
Publikováno v:
International Journal of Business Innovation and Research; 2022, Vol. 27 Issue: 3 p395-412, 18p
Autor:
Kothari, Atul1 dratulkothari@gmail.com, Sagar, Vishal2
Publikováno v:
Journal of Infection in Developing Countries. 2008, Vol. 2 Issue 5, p354-358. 5p.
Autor:
Sagar, Vishal *, Lederer, Eleanor
Publikováno v:
In American Journal of Kidney Diseases February 2004 43(2)
Autor:
Doddi, Sudeendra1 sdoddi@nhs.net, Sagar, Vishal1, Singhal, Tarun1, Balakrishnan, Santosh1, Smedley, Frank1, Sinha, Prakash
Publikováno v:
Case Reports in Medicine. 2010, p1-3. 3p. 1 Color Photograph, 1 Black and White Photograph.
Publikováno v:
International Journal of Intellectual Property Management. 7:1
505(b)(2) application is one of the three established types of regulatory submission and may be advantageous for pharmaceutical sponsors. The 505(b)(2) regulatory submission is defined in FFDC act as an NDA containing investigations of safety and eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e8e90b53aef32e5bb278b43d95c614b
https://doi.org/10.1504/ijipm.2014.062781
https://doi.org/10.1504/ijipm.2014.062781
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.